These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 34917152)

  • 21. State of the Art of Cardiac Amyloidosis.
    Belfeki N; Ghriss N; Monchi M; Moini C
    Biomedicines; 2023 Mar; 11(4):. PubMed ID: 37189662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac amyloidosis: Recent advances in the diagnosis and therapy.
    Çavuşoğlu Y; Özpelit E; Çelik A; İkitimur B; Kayıkçıoğlu M; Tokgözoğlu L; Tüfekçioğlu O; Yılmaz MB
    Turk Kardiyol Dern Ars; 2019 Jun; 47(Suppl 2):1-34. PubMed ID: 31364995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transthyretin cardiac amyloidosis: an update on diagnosis and treatment.
    Yamamoto H; Yokochi T
    ESC Heart Fail; 2019 Dec; 6(6):1128-1139. PubMed ID: 31553132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic impact of light-chain and transthyretin-related categories in cardiac amyloidosis: A systematic review and meta-analysis.
    Xin Y; Hu W; Chen X; Hu J; Sun Y; Zhao Y
    Hellenic J Cardiol; 2019; 60(6):375-383. PubMed ID: 30742933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accelerated junctional rhythm (AJR) revealing light-chain cardiac amyloidosis: A case report with literature review.
    Faraj R; Bourouhou Z; Oussama S; Bouamoud A; Rami H; Samih A; Fellat I; Zarzur J; Cherti M
    Ann Med Surg (Lond); 2022 Mar; 75():103410. PubMed ID: 35386774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosing cardiac amyloidosis in every-day practice: A practical guide for the cardiologist.
    Papathanasiou M; Carpinteiro A; Rischpler C; Hagenacker T; Rassaf T; Luedike P
    Int J Cardiol Heart Vasc; 2020 Jun; 28():100519. PubMed ID: 32373710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transthyretin amyloidosis: an under-recognized neuropathy and cardiomyopathy.
    Galant NJ; Westermark P; Higaki JN; Chakrabartty A
    Clin Sci (Lond); 2017 Mar; 131(5):395-409. PubMed ID: 28213611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac Amyloidosis for the Primary Care Provider: A Practical Review to Promote Earlier Recognition of Disease.
    Zhang KW; Vallabhaneni S; Alvarez-Cardona JA; Krone RJ; Mitchell JD; Lenihan DJ
    Am J Med; 2021 May; 134(5):587-595. PubMed ID: 33444590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new therapy for transthyretin amyloidosis, no longer an orphan condition.
    Quarta CC; Tinuper AL; Milandri A; Gagliardi C; Caponeti G; Rapezzi C
    Eur Heart J Suppl; 2020 Jun; 22(Suppl E):E125-E131. PubMed ID: 32523456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emerging Therapies for Transthyretin Cardiac Amyloidosis.
    Alexander KM; Evangelisti A; Witteles RM
    Curr Treat Options Cardiovasc Med; 2019 Jul; 21(8):40. PubMed ID: 31309347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. From Clinical Clues to Final Diagnosis: The Return of Detective Work to Clinical Medicine in Cardiac Amyloidosis.
    Sabbour H; Hasan KY; Al Badarin F; Alibazoglu H; Rivard AL; Romany I; Perlini S
    Front Cardiovasc Med; 2021; 8():644508. PubMed ID: 34262948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Refractory Heart Failure of Unknown Etiology May Be Cardiac Amyloid If Preceded by Hereditary Neurological Symptoms.
    Mene-Afejuku T; Akinlonu AA; Graham AN; Akinboboye O
    Cureus; 2020 Jul; 12(7):e9392. PubMed ID: 32850258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of Cardiac Amyloidosis: Do's and Don'ts.
    Alexander KM; Witteles RM
    Can J Cardiol; 2020 Mar; 36(3):444-446. PubMed ID: 32033795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Straining Heart: Transthyretin Amyloidosis as a Cause of Heart Failure.
    Tender-Vieira J; Pinto C; Matias P; Marques P; Almeida JS
    Cureus; 2023 Dec; 15(12):e50957. PubMed ID: 38249187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Senile Systemic Amyloidosis: An Underdiagnosed Disease.
    Manso MC; Marques DP; Rocha SL; Rodeia SC; Domingos R
    Eur J Case Rep Intern Med; 2017; 4(9):000725. PubMed ID: 30755970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strong transthyretin immunostaining: potential pitfall in cardiac amyloid typing.
    Satoskar AA; Efebera Y; Hasan A; Brodsky S; Nadasdy G; Dogan A; Nadasdy T
    Am J Surg Pathol; 2011 Nov; 35(11):1685-90. PubMed ID: 21945954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-Val30Met mutation, septal hypertrophy, and cardiac denervation in patients with mutant transthyretin amyloidosis.
    Hirakawa K; Takashio S; Marume K; Yamamoto M; Hanatani S; Yamamoto E; Sakamoto K; Izumiya Y; Kaikita K; Oda S; Utsunomiya D; Shiraishi S; Ueda M; Yamashita T; Yamashita Y; Ando Y; Tsujita K
    ESC Heart Fail; 2019 Feb; 6(1):122-130. PubMed ID: 30284755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current Therapies and Future Horizons in Cardiac Amyloidosis Treatment.
    Vogel J; Carpinteiro A; Luedike P; Buehning F; Wernhart S; Rassaf T; Michel L
    Curr Heart Fail Rep; 2024 May; ():. PubMed ID: 38809394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis of Transthyretin Amyloid Cardiomyopathy.
    Hafeez AS; Bavry AA
    Cardiol Ther; 2020 Jun; 9(1):85-95. PubMed ID: 32266575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings.
    Vergaro G; Aimo A; Barison A; Genovesi D; Buda G; Passino C; Emdin M
    Eur J Prev Cardiol; 2020 Nov; 27(17):1806-1815. PubMed ID: 31581822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.